# E-reporting of Adverse Drug Reactions by Patients in Relapsing-remitting Multiple Sclerosis

> **NCT03029897** · NA · COMPLETED · sponsor: **University Hospital, Caen** · enrollment: 161 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **OTHER:** My eReport France

## Key facts

- **NCT ID:** NCT03029897
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-05
- **Primary completion:** 2019-04-24
- **Final completion:** 2019-04-24
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2019-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03029897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03029897, "E-reporting of Adverse Drug Reactions by Patients in Relapsing-remitting Multiple Sclerosis". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03029897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*